In breast cancer, FGF2 mRNA expression positively correlates with CAF abundance, and siRNA silencing of FGFR1 in MDA-MB-231 breast cancer cells co-implanted with FGF2+ CAFs significantly reduced xenograft tumor burden [304]. The gene discussed is FGF2; the disease is neoplasm.